Quest PharmaTech Inc

Type: Company
Name: Quest PharmaTech Inc
First reported Jul 14 2014 - Updated Jul 15 2014 - 1 reports

Prostate Cancer - Pipeline Review, H1 2014 - New Market Research Report

Boston, MA -- ( SBWIRE ) -- 07/14/2014 -- Global Markets Direct's, 'Prostate Cancer - Pipeline Review, H1 2014', provides an overview of the Prostate Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development ... [Published SBWire - Jul 14 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

"Polymeric Nanoparticles for Photosensitizers" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors Haddadi, Azita (Saskatoon, CA); Madiyalakan, Ragupathy (Edmonton, CA); Woo, Thomas (Edmonton, CA), filed on August 11, 2011, was made available online on June 26, ... [Published Wall Street Business Network - Jul 03 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

"Polymeric Nanoparticles for Photosensitizers" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors Haddadi, Azita ( Saskatoon , CA); Madiyalakan, Ragupathy ( Edmonton , CA); Woo, Thomas ( Edmonton , CA), filed on August 11, 2011 , was made available online on ... [Published HispanicBusiness.com - Jul 03 2014]
First reported Jun 09 2014 - Updated Jun 09 2014 - 1 reports

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

TSX Venture: QPTEDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has ... [Published PR Newswire: Health - Jun 09 2014]

Quotes

"FIG. 7 shows the response of SCCVII tumours to PDT mediated by three different formulations of the present nanoparticles using a 4 hour interval between photosensitizer administration and light treatment;"

More Content

All (5) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Prostate Cancer - Pipeline Review, H1 2014 - Ne... [Published SBWire - Jul 14 2014]
"Polymeric Nanoparticles for Photosensitizers" ... [Published Wall Street Business Network - Jul 03 2014]
"Polymeric Nanoparticles for Photosensitizers" ... [Published HispanicBusiness.com - Jul 03 2014]
Quest PharmaTech Completes Patient Enrollment i... [Published PR Newswire: Health - Jun 09 2014]
Quest and Oncovir to evaluate combinatorial imm... [Published Pharmaceutical Technology - Jan 31 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Quest PharmaTech Completes Patient Enrollment i... [Published PR Newswire: Health - Jun 09 2014]
TSX Venture: QPTEDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.